AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇲🇼
ALBENDAZOLE USP in Malawi
5 products registered with PMRA — 0 active, 5 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ALBEZOLE 200MG TABLET TABLET | PMPB/PL161/1 | — | expired | 31 Mar 2025 |
| ANTHEL 200MG/5ML SUSPENSION SUSPENSION | PMPB/PL359/4_ | — | expired | 31 Mar 2024 |
| NUBEND 400MG TABLET TABLET | PMPB/PL89/10 | — | expired | 31 Mar 2024 |
| COBEND-S 200MG SUSPENSION SUSPENSION | PMPB/PL413/5 | — | expired | 30 Jun 2016 |
| ALBUZOL-200 200MG CHEWABLE TABLETS CHEWABLE TABLETS | PMPB/PL77/24 | — | expired | 30 Jun 2014 |
ALBENDAZOLE USP — PMRA Registration Details
PMRA (Malawi) has 5 registered products containing ALBENDAZOLE USP, of which 0 are currently active. Data is sourced directly from the official PMRA drug register and refreshed daily.
Track ALBENDAZOLE USP registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.